Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from BICO Group AB Class B ( (SE:BICO) ).
BICO Group AB has strengthened its capital structure by issuing EUR 40 million in senior secured bonds under a EUR 60 million framework, with a four‑year term and a floating rate of three‑month EURIBOR plus 5.90 percentage points, priced at 96.81% of par. The net proceeds will be used for general corporate purposes and provide additional financial flexibility as the company prepares to repay its outstanding SEK 1,008 million in convertible bonds at maturity in March 2026, a move management says enhances BICO’s liquidity, supports future growth plans and positions the company to benefit from a potential market recovery amid ongoing macroeconomic uncertainty.
The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK18.00 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.
More about BICO Group AB Class B
BICO Group AB is a lab automation partner and provider of selected workflows to the pharma and biotech industries. With more than 48,000 instruments installed in over 65 countries and solutions used in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, BICO operates through two business areas – Lab Automation and Life Science Solutions – and is listed on the Nasdaq Stockholm Mid-Cap market.
Average Trading Volume: 207,297
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.28B
See more insights into BICO stock on TipRanks’ Stock Analysis page.